S
Sasithon Pukrittayakamee
Researcher at Mahidol University
Publications - 209
Citations - 13552
Sasithon Pukrittayakamee is an academic researcher from Mahidol University. The author has contributed to research in topics: Malaria & Plasmodium falciparum. The author has an hindex of 60, co-authored 195 publications receiving 11873 citations. Previous affiliations of Sasithon Pukrittayakamee include John Radcliffe Hospital & Novartis.
Papers
More filters
Journal ArticleDOI
Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
Rie Takeuchi,Saranath Lawpoolsri,Mallika Imwong,Jun Kobayashi,Jaranit Kaewkungwal,Sasithon Pukrittayakamee,Supalap Puangsa-art,Nipon Thanyavanich,Wanchai Maneeboonyang,Nicholas P. J. Day,Pratap Singhasivanon +10 more
TL;DR: Adherence to the 14-day primaquine regimen is important for the radical cure of P. vivax malaria infection, and implementation of DOT reduces the reappearance rate of the parasite, and may subsequently decrease P.vivax transmission in the area.
Journal ArticleDOI
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Ghulam Rahim Awab,Sasithon Pukrittayakamee,Mallika Imwong,Arjen M. Dondorp,Arjen M. Dondorp,Charles J. Woodrow,Charles J. Woodrow,Sue Jean Lee,Sue Jean Lee,Nicholas P. J. Day,Nicholas P. J. Day,Pratap Singhasivanon,Nicholas J. White,Nicholas J. White,Faizullah Kaker +14 more
TL;DR: In a setting where radical therapy cannot be administered, dihydroartemisinin-piperaquine provides additional benefit in terms of post-treatment prophylaxis, reducing the incidence of recurrence from 4-8 weeks after treatment.
Journal ArticleDOI
Disposition of oral quinine in acute falciparum malaria.
Wichai Supanaranond,Timothy M. E. Davis,Timothy M. E. Davis,Sasithon Pukrittayakamee,Kamolrat Silamut,Juntra Karbwang,P. Molunto,L. Chanond,Nicholas J. White,Nicholas J. White +9 more
TL;DR: High blood concentrations following the administration of oral quinine in acute malaria are probably related to increased plasma protein binding, lower apparent volume of distribution, and a reduction in its systemic clearance.
Journal ArticleDOI
Antimalarial effects of rifampin in Plasmodium vivax malaria.
Sasithon Pukrittayakamee,C Viravan,P. Charoenlarp,C. Yeamput,R. J. M. Wilson,Nicholas J. White +5 more
TL;DR: It is suggested that rifampin at the usual therapeutic doses has partial activity against blood stages of P. vivax in humans but that used alone it is insufficient for cure, and might therefore be of value in combination antimalarial therapy.
Journal ArticleDOI
Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.
Kerryn A. Moore,Kerryn A. Moore,Julie A. Simpson,Jacher Wiladphaingern,Aung Myat Min,Mupawjay Pimanpanarak,Moo Kho Paw,Jathee Raksuansak,Sasithon Pukrittayakamee,Freya J. I. Fowkes,Freya J. I. Fowkes,Freya J. I. Fowkes,Nicholas J. White,Nicholas J. White,François Nosten,François Nosten,Rose McGready,Rose McGready +17 more
TL;DR: Malaria control and elimination efforts in the general population can avert the adverse consequences associated with treated asymptomatic malaria in pregnancy and protection against malaria should be started as early as possible in pregnancy.